Shlomo Ben-haim MD

Professor Shlomo Ben-Haim is an entrepreneur in the field of medical technology, with a long and successful record of exits. He is co-founder of a number of successful medical device and biomedical companies, covering the fields of cardiology, obesity, esthetics and cosmetics, anti-viral medication, deep vein thrombosis prevention, therapy for limb ischemia, and post-stroke and sports injuries rehabilitation.

In addition to his significant expertise and experience within the medical device industry, Professor Ben-Haim has also been effective in developing and maximizing the value of his companies. Working with his partners, he oversaw the merger of 12 of the companies he co-founded with leading industry multinationals, in deals valued at over $1 billion, including the sale of Biosense to Johnson & Johnson for $427 million, the merger of X-Technologies with Guidant, and the sale of Spectrum Dynamics to Biosensors Group International.